[Glycyrrhetinic acid selectively inhibits proliferation of hepatocellular carcinoma cells in vitro]

Nan Fang Yi Ke Da Xue Xue Bao. 2018 Apr 20;38(4):477-482. doi: 10.3969/j.issn.1673-4254.2018.04.18.
[Article in Chinese]

Abstract

Objective: To investigate the selective inhibitory effect of glycyrrhetinic acid on 4 hepatocellular carcinoma (HCC) cells with different proliferation rates and explore the underlying mechanisms.

Methods: MTT method was used to detect the proliferation rates of 4 HCC cell lines, namely SMMC-7721, SK-HEP1, HEPG2 and HEP3B. Following treatment of the cells with glycyrrhetinic acid (5, 10, 20, 30, 40, and 60 µmol/L), the cell viability was analyzed using MTT assay and the expressions of total ERK protein, p-ERK protein and topoisomerase IIα were detected using Western blotting.

Results: Among the 4 cell lines, SMMC-7721 had the lowest and SK-HEP1 had the highest proliferation rate. Treatment with glycyrrhetinic acid for 48 h dose-dependently inhibited the proliferation of all the 4 cell lines in vitro and produced the strongest inhibitory effect in SMMC-7721 cells with the IC50 of 28.04 µmol/L. The proliferation rate of the cells was positively correlated with the expression levels of p-ERK and topoisomerase IIα, which were the lowest in SMMC-7721 cells and the highest in SK-HEP1 cells. Treatment with 50 µmol/L glycyrrhetinic acid significantly down-regulated the expressions of p-ERK and topoisomerase IIα in the 4 HCC cell lines (P<0.05), while 25 µmol/L glycyrrhetinic acid significantly reduced the expression of topoisomerase IIα and p-ERK in SMMC-7721, HEPG2 and HEP3B cells (P<0.05) but not in SK-HEP1 cells.

Conclusion: Glycyrrhetinic acid can inhibit the proliferation of different HCC cells particularly in cells with a low proliferation rate. The inhibitory effect of glycyrrhetinic acid might be mediated by reducing the expressions of topoisomerase IIα and inhibiting the ERK pathway.

目的: 探讨甘草次酸对增殖速率不同的4株肝癌细胞SMMC-7721,SK-HEP1,HEPG2,HEP3B体外增殖的抑制作用及其机制。

方法: 通过MTT法测定肝癌SMMC-7721,SK-HEP1,HEPG2和HEP3B细胞株体外生长曲线;用梯度浓度甘草次酸(5、10、20、30、40、60 μmol/L)分别刺激48 h后,MTT法检测甘草次酸对4种肝癌细胞株体外生长的影响,Western blot实验考察其对4种肝癌细胞株总ERK蛋白,磷酸化ERK蛋白和拓扑异构酶Ⅱα蛋白表达的影响。

结果: 4株肝癌细胞中SMMC-7721细胞增殖速率最慢,而SK-HEP1细胞增殖速率最快;甘草次酸刺激48 h能浓度依赖性地抑制4种肝癌细胞的生长,其中对慢增殖细胞SMMC-7721细胞抑制作用最强(IC50为28.04 μmol/L);细胞内ERK的磷酸化,拓扑异构酶Ⅱα的表达与细胞增殖速率呈正相关,SMMC-7721细胞拓扑异构酶Ⅱα与p-ERK蛋白的表达在4株细胞中最低,SK-HEP1细胞表达最高。与阴性对照组相比,50 μmol/L的甘草次酸可显著抑制4株细胞内拓扑异构酶Ⅱα与p-ERK蛋白的表达(P < 0.05),而25 μmol/L的甘草次酸可显著下调SMMC-7721,HEPG2和HEP3B细胞拓扑异构酶Ⅱα与p-ERK蛋白(P < 0.05)而对SK-HEP1细胞没有作用。

结论: 甘草次酸对不同肝癌细胞生长的抑制作用有选择性。其中对慢增殖肝癌的治疗具有较好的抑制效果。下调拓扑异构酶Ⅱα的表达与抑制ERK通路的激活可能为其作用机制之一。

MeSH terms

  • Carcinoma, Hepatocellular / pathology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • DNA Topoisomerases, Type II / metabolism
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Glycyrrhetinic Acid / pharmacology*
  • Humans
  • Liver Neoplasms / pathology*

Substances

  • Extracellular Signal-Regulated MAP Kinases
  • DNA Topoisomerases, Type II
  • Glycyrrhetinic Acid

Grants and funding

广东省自然科学基金(2015A030313281)